SWEHSC Member Highlights Archives

Thom Melendez, Associate Director for Bio5, talks about his passion for outreach education, his involvement with Bio5 and KEYS, and how his history in education has shaped him for his role as associate director.

Bernard W. Futscher, a professor of pharmacology and toxicology in the UA College of Pharmacy and scientific director of the Arizona Cancer Center's genomics shared service. Futscher's longstanding cancer research interest is in the area epigenetics - the study of the control of cell identity and be read more...

This unique multi-disciplinary effort is spearheaded by Dr. Donata Vercelli, who is renowned for her work in allergies and asthma genetics and is director of the center, also known as ABCD.

On Thursday, December 3rd, 2009, Dr. Fernando Martinez was formally inducted as a UA Regents' Professor.

Paloma Beamer (Research Focus Group 2) of the University of Arizona Southwest Environmental Health Sciences Center spends a lot of her time thinking about dust, what it's made of and where it comes from.

Stephen H. Wright, PhD, professor in the Department of Physiology at the University of Arizona College of Medicine, is the recipient of this year's Faculty Science Forum Founders Day Award. Dr. Wright also is a professor in the UA Department of Biochemistry & Molecular Biophysics.

One of the most highly regarded researchers worldwide in childhood lung diseases, Dr. Fernando Martinez,SWEHSC Member - Research Focus Group 2, has accepted the position of director for the BIO5 Institute at the University of Arizona.

Dr. Jeff Burgess has been awarded $2.3 million for two national research grants to study and prevent injuries among firefighters.

Dr. George Watts is an engaged and enthusiastic Cancer Genome Biologist using innovative cutting edge research to better understand and treat human disease.

Serrine Lau, professor at the University of Arizona College of Pharmacy, and a team of UA researchers have received a two-year National Institutes of Health Challenge Grant of $937,302 to study how dogs present in the home near the time of a child's birth decrease his or her chance of developing ast read more...

Working with the chemical VCD has led to a rewarding and productive career for UA Physiology Professor Dr. Patricia Hoyer. Otherwise known as 4-vinylcyclohexine diepoxide, VCD is an industrial solvent that Dr. Hoyer has used to develop a mouse model to study peri- and postmenopausal conditions. It w read more...

Heddwen Brooks, member of the SW Hazardous Environmental Exposure research focus group of the SWEHSC, received an ADVANCE award in collaboration with Dr. Janet Funk to explain what happens to kidney function with the loss of estrogen and other changes associated with menopause.

The $3.3 million, five-year "ADVANCE Institutional Transformation Award: Eradicating Subtle Discrimination in the Academy," carries a three-fold mission: to promote faculty diversity, create an equitable climate within the institution and to support women toward leadership roles and careers in scien read more...

Dr Zhang was one of the first ONES grantschosen from more than 70 applicants through a rigorous application, review, and interview process.

Serrine Lau, professor and toxicologist at The University of Arizona, will receive the 2009 Education Award from the Society of Toxicology in March.

One of the most highly regarded researchers worldwide in childhood lung diseases, Fernando Martinez, has accepted the position of interim director for the BIO5 Institute at The University of Arizona (UA) beginning February 9, 2009.

Dr. Raymond B.Runyan has been appointed Chairperson of the Cardiovascular Differentiation and Development Study Section at the Center for Scientific Review, National Institutes of Health.

The National Council on Drug Abuse has awarded Terrence J. Monks, head of the University of Arizona College of Pharmacy's Department of Pharmacology and Toxicology, $1.7 million for a nearly five-year study of the long-term adverse effects of the street drug ecstasy, also known as the "hug drug."

A new team of researchers from UA and ASU is taking aim at the sixth leading cause of death in the United States: type 2 diabetes. The coalition's goal is to learn how to predict who will eventually develop the disease long before any symptoms appear.

Recently, Dr. Vaillancourt mentored a high school student from the BASIS Senior Internship program. The UA SWEHSC Community, Outreach & Education Core collaborates with BASIS to recruit those students who are in good academic standing and have a strong interest in bio-medical research. Two BASIS read more...

Walter Klimecki, PhD, assistant professor, Pharmacology and Toxicology, was a presenter in the discussion “Genetics & the Drug Industry (Pharmacogenetics).” The discussion was part of the one-day Genetics & Society Roundtable sponsored Sept. 19 by BIO5 Institute, the James E. Rogers College of Law a

The National Institutes of Health awarded The University of Arizona a five-year, $1.4 million grant for HuGER, which will be a multidisciplinary training ground that will give student researchers the expertise to better understand how genes and the environment interact to affect human health.

Founded as a university spin-off in 1997 by Elaine Jacobson, PhD, and Myron Jacobson, PhD, faculty members in the UA College of Pharmacy, the Arizona Cancer Center and the BIO5 Institute, Niadyne, Inc. develops novel topical drugs for the treatment and prevention of skin cancer, other dermatological read more...

Dr. Lawrence Hurley is recognized as an Innovative Scientist at Innovation Day when UA celebrates technology development and commercialization through the research achievements of students, staff and faculty.

Raymond Runyan, Ph.D., a Heart Center researcher and a professor in the UA Department of Cell Biology and Anatomy, and a handful of other UA researchers have been chosen for a prestigious $8.8 million grant from the National Institutes of Health's National Heart, Lung and Blood Institute to study em read more...